News items related to: Public Statement
-
Patent Applications for HIV Prevention Drug Opposed in India: Vulnerable Group Seeks to Protect Generic Competition to Lower Prices of HIV Prevention Drug Lenacapavir
New Delhi, 18 September 2024 – The Indian Patent Office is set to hear the objections of Sankalp Rehabilitation Trust...
-
ITPC Sounds Alarm to Prevent Mpox Treatment Disparities as WHO Declares Global Health Emergency
July 15, 2024 — ITPC Global welcomes the World Health Organization’s (WHO) declaration of the current mpox upsurge as a Public...
-
Ending the Epidemic Could Cost Under $40 (per person, per year) – treatment activists say at AIDS2024
Munich, 23 July 2024 – Despite global efforts to end HIV and AIDS, the epidemic has been persistent. In 2022,...
-
TBPeople: fighting for affordable medicines in Georgia
-
World Community Advisory Board 2023
ITPC organized a World Community Advisory Board Meeting (WCAB) which took place from November 29th to December 1st, in Amsterdam,...
-
People’s Resolution: A Roadmap to Protect the Right to Life in a Failed Multilateral Order
We, as members of communities, civil society and activists affected by epidemics, call for a plan of action to end...
-
Activists Across the World Demand Urgent Action to Improve Access to Lifesaving Tuberculosis (TB) Medicine, Bedaquiline
July 1, 2022 – A new generic version of bedaquiline produced by Macleods Pharmaceuticals in India has cleared the Global...
-
MPP-Merck Molnupiravir License Reveals the Limits of Voluntary Measures During a Pandemic
On 27th October 2021, Merck Sharpe Dohme (MSD) and the Medicines Patent Pool (MPP) announced a voluntary licensing agreement covering...
